Shaped porous carbon products and processes for preparing these products are provided. The shaped porous carbon products can be used, for example, as catalyst supports and adsorbents. Catalyst compositions including these shaped porous carbon products, processes of preparing the catalyst compositions, and various processes of using the shaped porous carbon products and catalyst compositions are also provided.

The invention provides methods of preparing 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid and methods of making a pharmaceutical material comprising a purified amount of 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid. Also provided are compositions and pharmaceutical materials including a purified amount of 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid as well as methods of treating various diseases and conditions using the compositions and pharmaceutical materials.

The invention provides methods of preparing 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid and methods of making a pharmaceutical material comprising a purified amount of 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid. Also provided are compositions and pharmaceutical materials including a purified amount of 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid as well as methods of treating various diseases and conditions using the compositions and pharmaceutical materials.

The present invention provides a porous metal-containing carbon-based material that is stable at high temperatures under aqueous conditions. The porous metal-containing carbon-based materials are particularly useful in catalytic applications. Also provided, are methods for making and using porous shaped metal-carbon products prepared from these materials.

The present invention provides a porous metal-containing carbon-based material that is stable at high temperatures under aqueous conditions. The porous metal-containing carbon-based materials are particularly useful in catalytic applications. Also provided, are methods for making and using porous shaped metal-carbon products prepared from these materials.

In a first aspect, the present invention is directed to a process for forming a metal alloy catalyst. Another aspect of the present invention is directed to a process for oxidizing a substrate that includes contacting a substrate with an oxidant in the presence of a metal alloy catalyst to form one or more carboxylic acids. Suitable substrates include sugars, polyols, furfural alcohols, and polyhydroxycarboxylic acids. The oxidation process may use the alloy catalyst formed from the process of the first aspect of the invention.

In a first aspect, the present invention is directed to a process for forming a metal alloy catalyst. Another aspect of the present invention is directed to a process for oxidizing a substrate that includes contacting a substrate with an oxidant in the presence of a metal alloy catalyst to form one or more carboxylic acids. Suitable substrates include sugars, polyols, furfural alcohols, and polyhydroxycarboxylic acids. The oxidation process may use the alloy catalyst formed from the process of the first aspect of the invention.

A method for preparing bio adipic acid includes steps of (a) preparing a glucaric acid potassium salt by mixing and reacting glucose, nitric acid (HNO.sub.3), sodium nitrite (NaNO.sub.2) and potassium hydroxide (KOH), (b) preparing glucamide from the glucaric acid potassium salt prepared in the step (a), (c) preparing 2,4-hexadiene diamide by performing a deoxydehydration reaction on the glucamide prepared in the step (b), (d) preparing adipamide by introducing the 2,4-hexadiene diamide prepared in the step (c), hydrogen and a hydrogenation catalyst to a reactor and performing a hydrogenation reaction, and (e) preparing adipic acid by introducing the adipamide prepared in the step (d) and an aqueous hydrochloric acid solution to a reactor and then performing a hydrolysis reaction at a specific temperature.

A method for preparing bio adipic acid includes steps of (a) preparing a glucaric acid potassium salt by mixing and reacting glucose, nitric acid (HNO.sub.3), sodium nitrite (NaNO.sub.2) and potassium hydroxide (KOH), (b) preparing glucamide from the glucaric acid potassium salt prepared in the step (a), (c) preparing 2,4-hexadiene diamide by performing a deoxydehydration reaction on the glucamide prepared in the step (b), (d) preparing adipamide by introducing the 2,4-hexadiene diamide prepared in the step (c), hydrogen and a hydrogenation catalyst to a reactor and performing a hydrogenation reaction, and (e) preparing adipic acid by introducing the adipamide prepared in the step (d) and an aqueous hydrochloric acid solution to a reactor and then performing a hydrolysis reaction at a specific temperature.

The present invention relates to novel hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, pancreatitius, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.